-
Analysis of risk factors affecting the postoperative prognosis of patients with hepatocellular carcinoma:a single-center analysis
- HUANG Rui-qin, HE Kun, QIAN Jun-lin, LUO Qi-jie
-
2023, 23(03):
205-214.
DOI: 10.3969/j.issn.1009-976X.2023.03.001
-
Asbtract
(
)
PDF (2435KB)
(
)
-
References |
Related Articles |
Metrics
Objective To investigate the independent risk factors affecting the postoperative prognosis of patients with hepatocellular carcinoma. Methods A retrospective analysis was conducted on 211 patients with hepatocellular carcinoma who underwent hepatectomy at Zhongshan People′s Hospital from June 1, 2017, to January 1, 2022. Cox regression analysis was used for univariate and multivariate analysis to determine the independent risk factors influencing disease-free survival and overall survival. Kaplan-Meier survival analysis was employed to evaluate the disease-free survival rate and overall survival rate associated with independent risk factors. Results According to multivariate analysis, alpha-fetoprotein (HR=1.000; 95%CI: 1.000-1.000; P=0.024), abnormal prothrombin (HR=1.000; 95%CI: 1.000-1.000; P=0.045), tumor diameter (HR=1.007; 95%CI: 1.001-1.015; P=0.008), portal vein tumor thrombus (HR=2.590; 95%CI: 1.215-4.132; P=0.023), microvascular invasion (HR=2.290; 95%CI: 1.282-4.161; P=0.001), satellite nodules (HR=2.185; 95%CI: 1.177-4.056; P=0.013), and tumor differentiation type (Medium/high differentiation: HR=1.127; 95%CI: 0.530-2.369; P=0.755; low/high differentiation: HR=2.468; 95%CI: 1.104-5.372; P=0.019) were identified as risk factors influencing patients′ disease-free survival. Tumor diameter (HR=1.011; 95%CI: 1.003-1.017; P=0.031), liver cirrhosis (HR=2.113; 95%CI: 1.057-3.233; P=0.043), microvascular invasion (HR=2.159; 95%CI: 1.531-5.238; P=0.029), satellite nodules (HR=2.778; 95%CI: 1.144-6.744; P=0.024), and tumor differentiation type (Medium/high differentiation: HR=1.896; 95%CI: 0.368-9.769; P=0.444; Low/high differentiation: HR=3.760; 95%CI: 1.745-8.989; P=0.024) were found to be risk factors affecting patients′ overall survival. The cumulative disease-free survival rates at 1 year, 2 years, and 3 years for CNLC stage I were significantly higher compared to CNLC stages Ⅱ-Ⅲa (81.0%-70.9%-66.9% vs. 61.8%-43.3%-30.3%, P<0.001). Similarly, the cumulative overall survival rates at 1 year, 2 years, and 3 years for CNLC stage I were also significantly higher than those for CNLC stages Ⅱ-Ⅲa (95.3%-89.5%-87.5% vs. 87.6%-57.6%-57.6%, P<0.001, Median disease-free survival of 17 months). Conclusion sAlpha-fetoprotein, abnormal prothrombin, portal vein tumor thrombus, tumor diameter, liver cirrhosis, microvascular invasion, satellite nodules, and tumor differentiation type are potential independent risk factors influencing patients′ prognosis. Furthermore, CNLC staging can better evaluate patients′ recurrence and survival outcomes.